To study the role of Pidd in clinical tumours, we measured its expression by quantitative reverse transcription-PCR in microdissected oral squamous cell carcinomas (OSCC) with and without p53 mutation. The gene discussed is PIDD1; the disease is oral cavity squamous cell carcinoma.